26th Annual St. Jude/PIDS Conference

Wednesday, March 3, 2027, 8:00 AM - Friday, March 5, 2027, 5:00 PM, St. Jude Children's Research Hospital, Memphis, TN

The 26th annual St. Jude-PIDS Pediatric Infectious Diseases Research Conference will be March 3-5, 2027 in Memphis, TN, and virtually.

This unique conference features leaders in the field of pediatric infectious diseases research, global health, transplant/immunocompromised hosts to share education, collaboration, and innovation for specialists pediatric infectious diseases training programs across the country.

Travel Stipends

Travel stipends of $1,000 USD are offered to accredited Pediatric Infectious Diseases Fellowship Training Programs (not individuals) based in the United States or Canada. A maximum of 35 stipends are made available on a first come, first served basis. The travel stipend application form is now open, and will close at 6:00 p.m. ET on February 12, 2027.

Cases

Case submissions are now being accepted for presentation during the Pediatric Transplant ID and Immunocompromised Hosts Challenging Cases session. Submissions will be reviewed and the best cases will be selected for presentation during the breakout sessions. Cases should not have been presented at other conferences or meetings, and may be submitted by infectious diseases fellows, residents, advanced practice providers (APP), or first year faculty members. More on requirements available here. The deadline to submit a case for consideration is 11:00 p.m. CT, Sunday, November 15.

Abstracts

Abstract submissions are open for General Research, Global Health, or Transplant/Immunocompromised Host ID. Abstracts should follow the structured format outlined on the linked portal to ensure a clear and concise presentation of research. Note: the poster session is only available for in-person presentation. The deadline to submit a case for consideration is 11:00 p.m. CT, Sunday, November 15.

1. Describe updates to current standards in the diagnosis, treatment and management of infectious complications in pediatric immunocompromised patients.
2. Explain advances in the management of infectious in transplant patients.
3. Identify opportunities and challenges during the transition from residency to fellowship and from fellowship to faculty.
4. Explain new developments in host-pathogen interaction, focusing on bacterial, viral and fungal infections.
5. Discuss global health-related opportunities for trainees and to share strategies for conducting clinical research in research limited settings.

Both in-person and virtual registration are now open. There is no fee associated with registering. In-person registration will remain open until February 14, 2027. Virtual registration will be available throughout the conference.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of St. Jude Children’s Research Hospital and the Pediatric Infectious Diseases Society. St. Jude Children’s Research Hospital is accredited by the ACCME to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (12.00 hours), Non-Physician Attendance (12.00 hours)

The official hotel for the 26th Annual St. Jude/PIDS Pediatric Infectious Diseases Research Conference will be the Hyatt Centric Beale Street Memphis. The special room rate of $199/night can be accessed here. The deadline for hotel reservations is February 1, 2027.

The faculty for this activity are listed below. Click to view the faculty member's financial disclosure information and bio. 

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.